Table 3.
Models estimated mean direct medical costs (including percentage change compared to Stage I), Euros 2021.
|
Model estimated Mean cost - Germany (% increase compared to Stage I) |
Lemhouer et al. (48) – Belgium (% increase compared to Stage I)* | Sun L. et al (4) – Systematic review (% increase compared to Stage I)** | Capri and Russo (15) - Italy (% increase compared to Stage I) |
Harfouche et al. (17) - Portugal (% increase compared to Stage I) |
Brandao et al. (49) - Portugal (% increase compared to Stage I) |
|
|---|---|---|---|---|---|---|
| DCIS | €9,838 | €9,063 | €9,744 | €5,429 | ||
| Stage I | €21,523 | €17,624 | €24,586 | €9,361 | €8,586 | €9,796 |
| Stage II | €25,679 (19.3%) | €25,209 (43%) | €32,525 (32%) | €11,169 (19%) | €13,786 (60%) | €13,839 (41%) |
| Stage III | €30,156 (40.1%) | €30,985 (76%) | €47,831 (95%) | €13,952 (49%) | €16,755 (95%) | €15,957 (63%) |
| Stage IV | €42,086 (95.5%) | €7,581* | €51,372 (109%) | €13,318 (42%) | €20,478 (138%) | - |
DCIS, Ductal Carcinoma In Situ. *only two patients in Stage IV for cost estimation **The cumulative mean of all studies included in the systematic review (nine studies from US, four from European Union, and eight from other countries world-wide). Source: Authors' elaboration.